Ashley Brunmeier1,2, Michael P Reis3, Michael G. Earing1,2, Laura Umfleet 4, Salil Ginde1,2, Peter J. Bartz1,2, Scott Cohen1,2
Congenital Heart Disease, Vol.13, No.5, pp. 728-733, 2018, DOI:10.1111/chd.12646
Abstract Objective: Children with congenital heart disease (CHD) and adults with acquired
heart disease are at an increased risk of neurocognitive impairment. The objective of
this study was to determine the prevalence of self‐reported neurocognitive impair‐
ment and its risk factors in the adult congenital heart disease (ACHD) population.
Design: The Wisconsin Adult Congenital Heart Disease Program recently began
screening ACHD patients to identify those with significant self‐perceived neurocog‐
nitive impairments. Screening consists of using a validated neuro‐oncology screening
instrument that has been modified for the ACHD population. Patients who answer
this survey in a predetermined fashion consistent… More >